Patrick J Mcenany - Insider Trading Tracker

촉매 제약, Inc.

US ˙ NasdaqCM ˙ US14888U1016

소개

이 페이지에서는 Patrick J Mcenany의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

가장 높은 순위의 내부자를 확인하세요

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Patrick J Mcenany 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권	소유권	최근 보고된 보유 주식
US:CPRX / Catalyst Pharmaceuticals, Inc.	Director	4,171,559
US:KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF	Director	122,750

차트 해석 방법

아래 차트는 Patrick J Mcenany에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자 매입 CPRX / Catalyst Pharmaceuticals, Inc.: 단기 이익 분석

이 섹션에서는 CPRX / Catalyst Pharmaceuticals, Inc.에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고 가격	최고 이익 ($)	최고 수익률 (%)
2020-09-30	CPRX	MCENANY PATRICK J	15,000	2.9700	15,000	2.9700	44,550	268	6.05	46,200	103.70
2019-10-03	CPRX	MCENANY PATRICK J	10,000	4.8900	10,000	4.8900	48,900
2019-06-11	CPRX	MCENANY PATRICK J	25,000	3.2300	25,000	3.2300	80,750
2018-12-19	CPRX	MCENANY PATRICK J	20,000	2.2400	20,000	2.2400	44,800
2018-04-03	CPRX	MCENANY PATRICK J	20,000	2.2900	20,000	2.2900	45,800
2017-09-05	CPRX	MCENANY PATRICK J	20,000	2.5780	20,000	2.5780	51,560
2016-06-14	CPRX	MCENANY PATRICK J	105,300	0.6508	105,300	0.6508	68,529
2016-04-26	CPRX	MCENANY PATRICK J	50,000	0.6486	50,000	0.6486	32,430
2015-12-28	CPRX	MCENANY PATRICK J	25,000	2.3890	25,000	2.3890	59,725
2015-10-01	CPRX	MCENANY PATRICK J	10,000	2.8100	10,000	2.8100	28,100
2015-04-27	CPRX	MCENANY PATRICK J	5,000	3.7900	5,000	3.7900	18,950
2015-01-08	CPRX	MCENANY PATRICK J	50,000	2.7950	50,000	2.7950	139,750
2014-05-21	CPRX	MCENANY PATRICK J	25,000	1.8890	25,000	1.8890	47,225
2014-02-07	CPRX	MCENANY PATRICK J	25,000	1.8200	25,000	1.8200	45,500
2013-10-21	CPRX	MCENANY PATRICK J	50,000	1.5946	50,000	1.5946	79,730
2013-02-19	CPRX	MCENANY PATRICK J	50,000	0.4600	50,000	0.4600	23,000
2012-12-17	CPRX	MCENANY PATRICK J	100,000	0.4450	100,000	0.4450	44,500
2012-11-15	CPRX	MCENANY PATRICK J	100,000	0.4201	100,000	0.4201	42,010
2012-07-03	CPRX	MCENANY PATRICK J	700	0.5350	700	0.5350	374
2012-07-02	CPRX	MCENANY PATRICK J	30,500	0.5383	30,500	0.5383	16,418
2012-05-30	CPRX	MCENANY PATRICK J	10,000	0.5790	10,000	0.5790	5,790
2012-05-24	CPRX	MCENANY PATRICK J	31,250	0.8000	31,250	0.8000	25,000
2012-02-14	CPRX	MCENANY PATRICK J	1,600	1.1000	1,600	1.1000	1,760
2012-02-14	CPRX	MCENANY PATRICK J	23,400	1.1500	23,400	1.1500	26,910

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

CPRX / Catalyst Pharmaceuticals, Inc. Insider Trades

내부자 매매 CPRX / Catalyst Pharmaceuticals, Inc.: 단기 손실 분석

이 섹션에서는 CPRX / Catalyst Pharmaceuticals, Inc.에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
2025-06-09	CPRX	MCENANY PATRICK J	171,748	26.1100	171,748	26.1100	4,484,340	108	19.1300	-1,198,801	-26.73
2025-06-06	CPRX	MCENANY PATRICK J	28,252	25.9450	28,252	25.9450	732,998
2024-11-20	CPRX	MCENANY PATRICK J	72,500	21.2900	72,500	21.2900	1,543,525
2024-11-19	CPRX	MCENANY PATRICK J	98,345	21.1880	98,345	21.1880	2,083,734
2024-11-14	CPRX	MCENANY PATRICK J	44,655	21.7520	44,655	21.7520	971,336
2024-11-13	CPRX	MCENANY PATRICK J	92,500	22.9780	92,500	22.9780	2,125,465
2024-11-12	CPRX	MCENANY PATRICK J	70,000	23.4210	70,000	23.4210	1,639,470
2024-11-12	CPRX	MCENANY PATRICK J	192,000	23.2010	192,000	23.2010	4,454,592
2024-11-11	CPRX	MCENANY PATRICK J	230,000	23.5480	230,000	23.5480	5,416,040
2023-05-15	CPRX	MCENANY PATRICK J	26,151	13.2300	26,151	13.2300	345,978
2022-11-21	CPRX	MCENANY PATRICK J	150,000	15.3320	150,000	15.3320	2,299,800
2022-11-18	CPRX	MCENANY PATRICK J	350,000	15.6220	350,000	15.6220	5,467,700
2022-09-14	CPRX	MCENANY PATRICK J	946,846	15.4140	946,846	15.4140	14,594,684
2022-09-13	CPRX	MCENANY PATRICK J	80,765	15.3290	80,765	15.3290	1,238,047
2022-08-19	CPRX	MCENANY PATRICK J	125,000	14.0994	125,000	14.0994	1,762,425
2022-08-18	CPRX	MCENANY PATRICK J	25,000	13.9340	25,000	13.9340	348,350
2022-08-18	CPRX	MCENANY PATRICK J	50,000	13.9300	50,000	13.9300	696,500
2022-08-18	CPRX	MCENANY PATRICK J	50,000	13.9590	50,000	13.9590	697,950
2022-08-18	CPRX	MCENANY PATRICK J	50,000	13.9510	50,000	13.9510	697,550
2021-08-23	CPRX	MCENANY PATRICK J	82,617	5.6250	82,617	5.6250	464,721
2021-08-20	CPRX	MCENANY PATRICK J	54,161	5.5180	54,161	5.5180	298,860
2021-08-13	CPRX	MCENANY PATRICK J	31,186	6.1740	31,186	6.1740	192,542
2021-08-13	CPRX	MCENANY PATRICK J	31,529	6.0745	31,529	6.0745	191,523

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

내부자 매입 KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF: 단기 이익 분석

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고 가격	최고 이익 ($)	최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF Insider Trades

내부자 매매 KOOL / Spinnaker ETF Series - North Shore Equity Rotation ETF: 단기 손실 분석

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일	티커	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Patrick J Mcenany의 내부자의 전체 거래 목록입니다.

보고일	거래일	보고	티커	증권	코드	지분	잔여 지분	변동률 (%)	지분 가치	거래 가치	잔여 가치
2025-12-30	2025-12-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-6,786	4,171,559	-0.16
2025-12-30	2025-12-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	26,334	4,178,345	0.63
2025-12-10	2025-12-08	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	3,534	4,152,011	0.09
2025-12-03	2025-12-01	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	G - Gift	-45,000	4,148,477	-1.07
2025-12-03	2025-12-01	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	G - Gift	-45,000	4,148,477	-1.07
2025-12-03	2025-12-01	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	G - Gift	-45,000	4,193,477	-1.06
2025-11-24	2025-11-21	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	1,775	4,283,477	0.04
2025-06-10	2025-06-09	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	S - Sale	-171,748	4,281,702	-3.86	26.11	-4,484,340	111,795,239
2025-06-10	2025-06-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	S - Sale	-28,252	4,453,450	-0.63	25.94	-732,998	115,544,760
2024-12-11	2024-12-09	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	3,533	4,481,702	0.08
2024-11-21	2024-11-20	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-72,500	4,478,169	-1.59	21.29	-1,543,525	95,340,218
2024-11-21	2024-11-20	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	72,500	4,550,669	1.62	3.54	256,650	16,109,368
2024-11-21	2024-11-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-98,345	4,478,169	-2.15	21.19	-2,083,734	94,883,445
2024-11-21	2024-11-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	98,345	4,576,514	2.20	3.54	348,141	16,200,860
2024-11-15	2024-11-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-44,655	4,478,169	-0.99	21.75	-971,336	97,409,132
2024-11-15	2024-11-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	44,655	4,522,824	1.00	3.54	158,079	16,010,797
2024-11-15	2024-11-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-92,500	4,478,169	-2.02	22.98	-2,125,465	102,899,367
2024-11-15	2024-11-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	92,500	4,570,669	2.07	3.54	327,450	16,180,168
2024-11-13	2024-11-12	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-192,000	4,478,169	-4.11	23.20	-4,454,592	103,897,999
2024-11-13	2024-11-12	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	192,000	4,670,169	4.29	3.54	679,680	16,532,398
2024-11-13	2024-11-12	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-70,000	4,478,169	-1.54	23.42	-1,639,470	104,883,196
2024-11-13	2024-11-12	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	70,000	4,548,169	1.56	4.01	280,700	18,238,158
2024-11-13	2024-11-11	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-230,000	4,478,169	-4.89	23.55	-5,416,040	105,451,924
2024-11-13	2024-11-11	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	230,000	4,708,169	5.14	4.01	922,300	18,879,758
2024-08-26	2024-08-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	G - Gift	-5,100	4,478,169	-0.11
2024-08-19	2024-08-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	G - Gift	-45,000	4,483,269	-0.99
2024-01-31	2024-01-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	116,667	4,528,256	2.64
2024-01-31	2024-01-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	26,333	4,411,589	0.60
2024-01-03	2024-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	250,000	4,385,256	6.05	1.13	282,500	4,955,339
2023-12-29	2023-12-27	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-10,362	4,135,256	-0.25
2023-12-29	2023-12-27	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	26,333	4,145,618	0.64
2023-05-17	2023-05-16	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	173,849	4,119,285	4.41	0.79	137,341	3,254,235
2023-05-17	2023-05-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-26,151	3,945,436	-0.66	13.23	-345,978	52,198,118
2023-05-17	2023-05-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	26,151	3,971,587	0.66	0.79	20,659	3,137,554
2023-02-17	2023-02-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-14,204	3,945,436	-0.36
2023-02-17	2023-02-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	58,333	3,959,640	1.50
2022-12-30	2022-12-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	G - Gift	-10,000	3,901,307	-0.26
2022-12-30	2022-12-28	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	G - Gift	-10,000	3,911,307	-0.26
2022-12-08	2022-12-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-12,133	3,921,307	-0.31
2022-12-08	2022-12-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	30,834	3,933,440	0.79
2022-11-22	2022-11-21	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-150,000	3,902,606	-3.70	15.33	-2,299,800	59,834,755
2022-11-22	2022-11-21	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	150,000	4,052,606	3.84	2.24	336,000	9,077,837
2022-11-22	2022-11-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-350,000	3,902,606	-8.23	15.62	-5,467,700	60,966,511
2022-11-22	2022-11-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	350,000	4,252,606	8.97	2.24	784,000	9,525,837
2022-09-15	2022-09-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-946,846	3,902,606	-19.52	15.41	-14,594,684	60,154,769
2022-09-15	2022-09-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-80,765	4,849,452	-1.64	15.33	-1,238,047	74,337,250
2022-08-19	2022-08-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-125,000	4,930,217	-2.47	14.10	-1,762,425	69,513,102
2022-08-19	2022-08-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	125,000	5,055,217	2.54	2.53	316,250	12,789,699
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-50,000	4,930,217	-1.00	13.95	-697,550	68,781,457
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	50,000	4,980,217	1.01	2.53	126,500	12,599,949
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock,. par value $0.001 per share	M - Exercise	50,000	4,980,217	1.01	2.53	126,500	12,599,949
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-50,000	4,930,217	-1.00	13.96	-697,950	68,820,899
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	50,000	4,980,217	1.01	2.53	126,500	12,599,949
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-50,000	4,930,217	-1.00	13.93	-696,500	68,677,923
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-25,000	4,930,217	-0.50	13.93	-348,350	68,697,644
2022-08-19	2022-08-18	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	25,000	4,955,217	0.51	2.53	63,250	12,536,699
2022-02-16	2022-02-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award	175,000	3,665,834	5.01
2021-12-30	2021-12-28	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	270,000	3,490,834	8.38
2021-12-06	2021-12-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	M - Exercise	-30,833	3,220,834	-0.95
2021-12-06	2021-12-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-12,132	4,930,227	-0.25
2021-12-06	2021-12-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	30,833	4,942,359	0.63
2021-08-24	2021-08-23	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise	-120,000	3,251,667	-3.56
2021-08-24	2021-08-23	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-82,617	4,911,526	-1.65	5.62	-464,721	27,627,334
2021-08-24	2021-08-23	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	120,000	4,994,143	2.46	3.12	374,400	15,581,726
2021-08-24	2021-08-20	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise	-80,000	3,371,667	-2.32
2021-08-24	2021-08-20	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-54,161	4,874,143	-1.10	5.52	-298,860	26,895,521
2021-08-24	2021-08-20	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	80,000	4,928,304	1.65	3.12	249,600	15,376,308
2021-08-17	2021-08-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise	-100,000	3,451,667	-2.82
2021-08-17	2021-08-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-31,529	4,848,304	-0.65	6.07	-191,523	29,451,023
2021-08-17	2021-08-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale	-31,186	4,879,833	-0.64	6.17	-192,542	30,128,089
2021-08-17	2021-08-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	100,000	4,911,019	2.08	3.12	312,000	15,322,379
2021-01-04	2020-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	400,000	3,551,667	12.69
2020-12-28	2020-12-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	M - Exercise	-30,833	3,151,667	-0.97
2020-12-28	2020-12-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	F - Taxes	-7,507	4,811,019	-0.16
2020-12-28	2020-12-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise	30,833	4,818,526	0.64
2020-09-30	2020-09-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	15,000	4,787,693	0.31	2.97	44,550	14,219,448
2019-12-04	2019-12-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award	92,500	3,182,500	2.99
2019-12-04	2019-12-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	740,000	3,090,000	31.49
2019-10-03	2019-10-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	10,000	4,772,693	0.21	4.89	48,900	23,338,469
2019-06-11	2019-06-11	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	25,000	4,762,693	0.53	3.23	80,750	15,383,498
2018-12-21	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,667	2,350,000	7.63
2018-12-21	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,667	2,350,000	7.63
2018-12-21	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,666	2,016,666	9.01
2018-12-19	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	20,000	4,737,693	0.42	2.24	44,800	10,612,432
2018-05-31	2018-05-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,667	1,850,000	9.90
2018-05-31	2018-05-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,667	1,850,000	9.90
2018-05-31	2018-05-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	166,666	1,516,666	12.35
2018-04-03	2018-04-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	20,000	4,717,693	0.43	2.29	45,800	10,803,517
2018-01-04	2018-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	1,350,000	8.00
2018-01-04	2018-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	1,350,000	8.00
2018-01-04	2018-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	1,250,000	8.70
2017-11-14	2017-11-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	M - Exercise	-26,667	0	-100.00
2017-11-14	2017-11-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	26,667	4,697,693	0.57
2017-11-07	2017-11-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise	-200,000	500,000	-28.57
2017-11-07	2017-11-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	200,000	4,671,026	4.47	0.47	94,000	2,195,382
2017-09-05	2017-09-05	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	20,000	4,471,026	0.45	2.58	51,560	11,526,305
2017-05-22	2017-05-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Warrants to Purchase Common Stock	X - Other	-31,250	0	-100.00	0.80	-25,000
2017-05-22	2017-05-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	31,250	4,451,026	0.71	1.04	32,500	4,629,067
2017-01-05	2017-01-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	83,334	1,250,000	7.14
2017-01-05	2017-01-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	83,333	1,166,666	7.69
2017-01-05	2017-01-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	83,333	1,166,666	7.69
2016-11-18	2016-11-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	M - Exercise	-26,667	26,667	-50.00
2016-11-18	2016-11-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	26,667	4,419,776	0.61
2016-06-17	2016-06-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	1,100,000	10.00
2016-06-17	2016-06-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	1,100,000	10.00
2016-06-14	2016-06-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	105,300	4,393,109	2.46	0.65	68,529	2,859,035
2016-04-26	2016-04-26	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	50,000	4,287,809	1.18	0.65	32,430	2,781,073
2016-01-04	2015-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	900,000	12.50
2016-01-04	2015-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	900,000	12.50
2016-01-04	2015-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award	100,000	800,000	14.29
2015-12-28	2015-12-28	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	25,000	4,237,809	0.59	2.39	59,725	10,124,126
2015-12-07	2015-12-07	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	M - Exercise	-26,666	53,334	-33.33
2015-12-07	2015-12-07	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	26,666	4,212,809	0.64
2015-10-30	2015-10-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise	-75,000	600,000	-11.11
2015-10-30	2015-10-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	F - Taxes	-26,119	4,186,143	-0.62
2015-10-30	2015-10-29	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise	75,000	4,212,262	1.81	1.09	81,750	4,591,366
2015-10-01	2015-10-01	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase	10,000	4,137,262	0.24	2.81	28,100	11,625,706
2015-04-27	2015-04-27	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	P - Purchase	5,000	4,127,262	0.12	3.79	18,950	15,642,323
2015-02-27	2015-02-25	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	M - Exercise	-364,804	786,250	-31.69
2015-02-27	2015-02-25	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	F - Taxes	-67,539	4,122,262	-1.61
2015-02-27	2015-02-25	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	M - Exercise	364,804	4,189,801	9.54	0.68	249,891	2,870,014
2015-01-08	2015-01-08	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	P - Purchase	50,000	3,970,918	1.28	2.80	139,750	11,098,716
2014-11-17	2014-11-13	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Restricted Stock Units	A - Award	26,667	1,151,054	2.37
2014-11-17	2014-11-13	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Restricted Stock Units	A - Award	26,667	1,151,054	2.37
2014-11-17	2014-11-13	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Restricted Stock Units	A - Award	26,666	1,097,720	2.49
2014-11-04	2014-08-28	4/A	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	100,000	1,221,054	8.92
2014-11-04	2014-08-28	4/A	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	100,000	1,121,054	9.79
2014-11-04	2014-08-28	4/A	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	100,000	1,021,054	10.86
2014-10-03	2014-10-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	M - Exercise	-150,000	1,231,054	-10.86
2014-10-03	2014-10-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	M - Exercise	150,000	3,920,918	3.98	0.90	135,000	3,528,826
2014-09-02	2014-08-28	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	153,334	1,381,054	12.49
2014-09-02	2014-08-28	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	153,333	1,227,720	14.27
2014-09-02	2014-08-28	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	153,333	1,227,720	14.27
2014-07-02	2014-07-01	4	KOOL	CESCA THERAPEUTICS INC. Option	A - Award	25,000	122,750	25.58
2014-05-21	2014-05-21	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	25,000	3,656,247	0.69	1.89	47,225	6,906,651
2014-02-07	2014-02-07	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	25,000	3,631,247	0.69	1.82	45,500	6,608,870
2013-10-21	2013-10-21	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	50,000	3,606,247	1.41	1.59	79,730	5,750,521
2013-07-02	2013-07-01	4	KOOL	THERMOGENESIS CORP Option	A - Award	15,000	109,000	15.96
2013-02-20	2013-02-19	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	50,000	3,556,247	1.43	0.46	23,000	1,635,874
2012-12-18	2012-12-17	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	100,000	3,449,997	2.99	0.44	44,500	1,535,249
2012-12-14	2012-12-12	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	66,667	936,054	7.67
2012-12-14	2012-12-12	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	66,667	936,054	7.67
2012-12-14	2012-12-12	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award	66,666	802,720	9.06
2012-11-15	2012-11-15	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	100,000	3,349,997	3.08	0.42	42,010	1,407,334
2012-07-05	2012-07-02	4	KOOL	THERMOGENESIS CORP Option	A - Award	15,000	100,500	17.54
2012-07-03	2012-07-03	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	700	3,249,997	0.02	0.54	374	1,738,748
2012-07-03	2012-07-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	30,500	3,249,297	0.95	0.54	16,418	1,749,097
2012-05-31	2012-05-30	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	10,000	3,218,797	0.31	0.58	5,790	1,863,683
2012-05-29	2012-05-24	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Warrants to Purchase Common Stock	P - Purchase	31,250	1,009,191	3.20
2012-05-29	2012-05-24	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	31,250	3,208,797	0.98	0.80	25,000	2,567,038
2012-02-14	2012-02-14	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	23,400	3,202,547	0.74	1.15	26,910	3,682,929
2012-02-14	2012-02-14	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase	1,600	3,179,147	0.05	1.10	1,760	3,497,062

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각

자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득

파생상품 전환

자사에게 유가증권을 매각 또는 양도

기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급

내부자에 의한 또는 내부자에게 증권 증여

지분스왑 및 유사 위험 회피거래

자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환

보고서 양식 4에 자진 신고된 거래

기타 (거래 내용을 설명하는 각주와 동반)